Ralf Kuriyel, Senior VP, R&D at REPLIGEN CORP (RGEN), sold 870 shares at $186.18 ($162K) on 2020-12-16, disclosed to the SEC on 2020-12-18.
Open-market sale of $162k RGEN by Senior VP, R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $186.18 | 435 | $81K | 50.0% |
| 2 | $186.18 | 435 | $81K | 50.0% |
| Total | $186.18 avg | 870 | $162K | 100% |
| Filing → |
| RGEN | SELL | 2024-03-12 | $1.4M | — | Filing → |
| RGEN | SELL | 2022-08-12 | $2.3M | — | Filing → |
| RGEN | SELL | 2021-09-02 | $2.3M | — | Filing → |